CorMedix Inc. (NASDAQ:CRMD)
Industry: Biotechnology

OFF LIST - 711 consecutive market days: OFF LIST as of 08/07/2013 Through 11/14/2016

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

Current Quote*
Last: $11.715
Change: 0.000
Book: $2.866
Volume: 1,156,818

As Of: 07/10 16:13 ET
*Quotes delayed by 20min.

Graphs for CRMD


3 Month Graph


6 Month Graph


1 Year Graph